PSMA-TB detected more csPCa lesions than systemic PB (81.7% vs. 76.7%, P < 0.001), whereas systemic PB can still have additional diagnostic benefits in 6.6% (4/60) patients 27. Here, FOLH1 is linked to tuberculosis.